Boeringer-Ingelheim Pharmaceuticals, Inc.

Member Type: Large Biotech/Pharmaceutical Companies

Boehringer Ingelheim has launched a campaign to educate healthcare providers about biomarker testing to personalize treatment for non-small cell lung cancer patients. Learn more about the "Let's Test" campaign here.

Join Today

PMC members shape and advance the future of personalized medicine.
Join Today

Download a Member List

Member List (PDF)